Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 6, 2019
[Cancer Immunotherapy Using Gene Modification Technology]Yoshihiro Tokunaga, Koji TamadaCancer Medicine|April 9, 2023
Therapeutic effects of anti-GM2 CAR-T cells expressing IL-7 and CCL19 for GM2-positive solid cancer in xenograft modelTakahiro Sasaki, Yukimi Sakoda, Keishi Adachi, et al.Molecular Cancer Therapeutics|October 22, 2021
Enhanced Antitumor Responses of Tumor Antigen-Specific TCR T Cells Genetically Engineered to Produce IL7 and CCL19Yoshihiro Tokunaga, Takahiro Sasaki, Shunsuke Goto, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 25, 2014
[Development of novel immunotherapy targeting cancer immune evasion]Koji TamadaCancer Science|May 19, 2015
Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacyKeishi Adachi, Koji TamadaGan to Kagaku Ryoho. Cancer & Chemotherapy|April 13, 2016
[Genome-Based Biomarkers of Immune Checkpoint Blockade Therapy]Keishi Adachi, Koji TamadaNihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Chimeric antigen receptor (CAR)-T cell therapyYukimi Sakoda, Koji TamadaCancer Science|September 1, 2022
Paving the road to make chimeric antigen receptor-T-cell therapy effective against solid tumorsKeishi Adachi, Koji TamadaJournal of Gastroenterology|July 14, 2018
Microbial biomarkers for immune checkpoint blockade therapy against cancerKeishi Adachi, Koji TamadaGan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2023
[Development of CAR-T Cells Effective against Solid Tumors]Keishi Adachi, Koji TamadaPageof 13